The Coca-Cola Company manufactures and sells nonalcoholic beverages in over 200 countries. Products include sparkling soft drinks, water, sports drinks, juice, dairy, and tea. Customers are bottling partners, fountain retailers, and retail outlets. [S2]
Sources through 2026-04-28 · Report dated 2026-09-15
Business details
How it makes money
KO sells beverage concentrates and syrups to bottling partners, which manufacture and distribute drinks. Concentrate operations were 59% of FY2025 revenue; finished-product operations were 41%. [S2][S3]
What drives results
Unit case volume growth determines concentrate sales and operating leverage. FY2025 volume flat; Q1 2026 grew 3%. [S2][S1]
Price/mix contributed 4% to FY2025 organic revenue growth and 2% in Q1 2026, reflecting pricing power. [S2][S1]
Comparable operating margin was 31.2% in FY2025 and 34.5% in Q1 2026, supported by organic revenue growth and operating leverage. [S2][S1]
Key dependencies
The global bottling system manufactures and distributes KO's products. Bottlers include Coca-Cola Europacific Partners and Coca-Cola FEMSA. [S3][S14]
Key inputs are sugar, high-fructose corn syrup, aluminum, PET resin, and juice concentrate. Input cost inflation pressured FY2025 and Q1 2026 margins. [S1][S2]
KO's wide-moat concentrate model and pricing power support steady cash generation, but volume growth is weak and the IRS dispute creates a material overhang. The central tension is whether mid-single-digit organic growth can persist without a return to volume growth, or whether the market overpays for safety.
The largest risk is that unit case volume remains flat or declines, forcing KO to rely on price/mix and exposing the valuation to margin compression. An adverse IRS ruling above $10bn would also impair capital allocation and could pressure the dividend.
Coca-Cola sells concentrates and syrups to bottling partners who make and distribute finished drinks. Concentrate operations were 59% of FY2025 revenue; finished-product operations 41%. The model is asset-light, with FY2025 gross margin near 62% and comparable operating margin 31.2%.
At $89.35, the market implies 4%-5% organic revenue growth, 32% comparable operating margin, 3% terminal growth, and a low cost of capital. It also embeds a manageable IRS outcome and continued dividend growth.
Base-case intrinsic value is about $92 per share, roughly 3% above the market price. Expected 3-to-5-year annualized return is 6%-7%, mostly from dividends and FCF growth, not multiple expansion. The stock is fairly valued with no margin of safety.
Present-value estimates at the analysis date; 10-year DCF with terminal growth, 7.0% WACC, 20% tax rate, 4,303M diluted shares; stock-based compensation treated as expense.
Scenarios are conditional estimates, not promised returns.
Bear · USD 72.0000
Volume stays flat, price/mix slows, margins compress to 29%-30%, and the IRS liability is $5bn-$8bn. FCF stagnates near $10bn-$11bn. Lower earnings and a 22x-24x multiple imply about $72 per share.
Volume returns to 1%-2%, price/mix 3%-4%, and comparable operating margin expands to 32%. Organic revenue grows 4%-5%, FCF reaches $15bn by 2030, and a 25x-27x multiple implies about $92 per share.
Emerging-market volume accelerates to 4%-5%, zero-sugar and premium mix improves, and the IRS dispute resolves manageably. Organic revenue grows 5%-6%, margin reaches 33%-34%, and a 28x-30x multiple implies about $110 per share.
I could not establish KO's R&D spending (not disclosed as a separate line), stock-based compensation (not stored in the platform data), or the precise maturity schedule of its debt. The timing and outcome of the IRS transfer-pricing dispute are unknown. I also could not independently verify the total addressable market for global NARTD beverages from a primary source; the industry growth estimates cited are my analysis based on KO's disclosed volume and revenue trends.